German studies highlight drug combo and potassium diet to cut hypertension treatment dropouts

A meta‑analysis of over 159,000 participants published in July 2026 found that combining a sartan (angiotensin‑II receptor blocker) with a calcium‑channel blocker reduced the risk of stopping hypertension therapy by 39% compared with other common regimens such as beta‑blocker plus thiazide diuretic. The authors attribute the improvement to better tolerability and complementary mechanisms of action.

A separate review recommends that dietary potassium intake be given equal emphasis to reduced salt consumption for blood‑pressure prevention. The authors argue that increasing potassium can further lower hypertension risk and should be incorporated into future nutrition guidelines.

Both pieces of research originate from German institutions and suggest practical changes for clinicians and policymakers to improve long‑term blood‑pressure control.